NCT01362452View on ClinicalTrials.gov

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 7, 2012

Primary Completion Date

July 25, 2017

Study Completion Date

July 25, 2017

Conditions
LeukemiaLymphoma
Interventions
GENETIC

T-Cell Infusion

Infusion of CD19-specific T cells derived from cord blood (CB) 42 days following stem cell transplantation.

PROCEDURE

Cord Blood Infusion

Cord blood infusion on Day 0.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT01362452 - Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells | Biotech Hunter | Biotech Hunter